Caltrate Plus
Natural health product licensed in Canada
- Licence holder
- Pfizer Consumer Healthcare, a division of Pfizer Canada ULC
- NPN or DIN-HM
- 80009761
- Status
- Inactive licence
- Licence date
- 23 April 2009
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 3.6 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Oxyde de zinc | 7.5 mg | 15,000 µg |
| Vitamine K1 Source : Vitamine K1 | 20 mcg | 40 µg |
| Manganèse Source : Sulfate de manganèse (II) monohydraté | 1.8 mg | 3,600 µg |
| Cuivre Source : Sulfate cuivrique anhydre | 1 mg | 2,000 µg |
Non-medicinal ingredients
Crosscarmellose sodium, Sucre de cane, Dioxyde de silicium, FD & C Rouge # 40, Oxyde de titane, Amidon de maïs, Stéarate de magnésium, ascorbate de sodium, Triacétine, Food starch, Vitamine E, Hypromellose, Poly(sorbate) 80, Phosphate de tricalcium, Microcrystalline cellulose, FD & C Jaune no. 6, Glucose, triglycérides à chaînes moyennes, FD & C bleu #1, acacia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium supplement with vitamins and minerals. Calcium intake when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps develop and maintain bones. Vitamin D to help calcium absorption. Vitamin K for the maintenance of bones. Calcium to help in the development and maintenance of bones and teeth. Magnesium to help in the development and maintenance of bones and teeth. Manganese to help in the development and maintenance of bones and teeth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80009761
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.